DPP4 and obesity due to melanocortin 4 receptor deficiency: Second, the increased DPP-4 activity was reported in T2DM when accompanied with a significant degree of insulin resistance (IR) [43], i.e., DPP-4 was recently proposed as a novel adipokine linking obesity to metabolic syndrome (MS) [45–47].